Biolog Device Balance Sheet Health
Financial Health criteria checks 6/6
Biolog Device has a total shareholder equity of ₩52.7B and total debt of ₩12.6B, which brings its debt-to-equity ratio to 23.9%. Its total assets and total liabilities are ₩89.8B and ₩37.1B respectively.
Key information
23.9%
Debt to equity ratio
₩12.61b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩7.31b |
| Equity | ₩52.69b |
| Total liabilities | ₩37.11b |
| Total assets | ₩89.80b |
Recent financial health updates
Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?
May 21
We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt
Mar 29Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet
Nov 25
Recent updates
Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks
Nov 14It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks
Jul 04Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?
May 21We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt
Mar 29Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet
Nov 25Financial Position Analysis
Short Term Liabilities: A208710's short term assets (₩43.3B) exceed its short term liabilities (₩36.8B).
Long Term Liabilities: A208710's short term assets (₩43.3B) exceed its long term liabilities (₩356.3M).
Debt to Equity History and Analysis
Debt Level: A208710's net debt to equity ratio (10.1%) is considered satisfactory.
Reducing Debt: A208710's debt to equity ratio has reduced from 25.4% to 23.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A208710 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A208710 has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 4.6% each year.